Literature DB >> 15728781

Hemolytic uremic syndrome.

Marina Noris1, Giuseppe Remuzzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15728781     DOI： 10.1681/ASN.2004100861

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  150 in total

1.  Seasonal variation of HUS occurrence and VTEC infection in children with acute diarrhoea from Argentina.

Authors:  M A Rivero; J A Passucci; E M Rodríguez; A E Parma
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-22       Impact factor: 3.267

2.  Shifting the Paradigm in Hemolytic Uremic Syndrome.

Authors:  David N Cornfield
Journal:  Pediatrics       Date:  2015-12-07       Impact factor: 7.124

3.  Atypical Hemolytic Uremic Syndrome in the Setting of Acute Clostridium difficile Colitis.

Authors:  Anshu Wadehra; Samer Alkassis
Journal:  Cureus       Date:  2021-02-09

4.  Endothelial health and diversity in the kidney.

Authors:  Mark S Segal; Chris Baylis; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2006-02       Impact factor: 10.121

5.  Molecular damage and induction of proinflammatory cytokines in human endothelial cells exposed to Shiga toxin 1, Shiga toxin 2, and alpha-sarcin.

Authors:  Maurizio Brigotti; Domenica Carnicelli; Elisa Ravanelli; Antonio González Vara; Chiara Martinelli; Roberta R Alfieri; Pier Giorgio Petronini; Piero Sestili
Journal:  Infect Immun       Date:  2007-02-12       Impact factor: 3.441

6.  Acquired thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome successfully treated with eculizumab.

Authors:  Appalanaidu Sasapu; Michele Cottler-Fox; Pooja Motwani
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

Review 7.  Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.

Authors:  Carlamaria Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2017-12-06       Impact factor: 3.714

8.  Lack of association between polymorphisms in C4b-binding protein and atypical haemolytic uraemic syndrome in the Spanish population.

Authors:  R Martínez-Barricarte; E Goicoechea de Jorge; T Montes; A G Layana; S Rodríguez de Córdoba
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

9.  Treatment of Atypical Hemolytic-Uremic Syndrome in the Era of Eculizumab.

Authors:  Rawaa Ebrahem; Salam Kadhem; Quoc Truong
Journal:  Cureus       Date:  2017-03-23

10.  Cyclosporine induces endothelial cell release of complement-activating microparticles.

Authors:  Brandon Renner; Jelena Klawitter; Ryan Goldberg; James W McCullough; Viviana P Ferreira; James E Cooper; Uwe Christians; Joshua M Thurman
Journal:  J Am Soc Nephrol       Date:  2013-10-03       Impact factor: 10.121
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.